News
We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that is said to have the potential to end the HIV pandemic.The new medication is ...
The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.
The FDA has accepted MSD’s doravirine/islatravir new drug application (NDA) for review to treat adults with virologically suppressed HIV-1.
The World Health Organisation (WHO) has called for the immediate global rollout of a breakthrough HIV drug, lenacapavir (LEN) ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...
This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
Whitman-Walker Health highlights the importance of PrEP in HIV prevention and encourages collective action to increase access ...
GENEVA, (CMC)-The World Health Organization (WHO) on Monday advised countries, including those in the Caribbean to ensure ...
A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results